{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:22:29Z","timestamp":1789428149808,"version":"build-2803163510"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA177932"],"award-info":[{"award-number":["CA177932"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016M3A9B5942352"],"award-info":[{"award-number":["2016M3A9B5942352"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jconrel.2019.04.040","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T20:26:50Z","timestamp":1557260810000},"page":"75-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration"],"prefix":"10.1016","volume":"305","author":[{"given":"Youjin","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joung-Pyo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinWoo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eonju","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Cheol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9466-4531","authenticated-orcid":false,"given":"Chae-Ok","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.04.040_bb0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2407-11-54","article-title":"Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma","volume":"11","author":"Jiang","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2015.10.009","article-title":"Polymeric oncolytic adenovirus for cancer gene therapy","volume":"219","author":"Choi","year":"2015","journal-title":"J. Control. Release Off. J. Control. Release Soc"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0015","series-title":"Current Cancer Drug Targets","first-page":"139","article-title":"Emergence of ad-mediated combination therapy against cancer: what to expect?","volume":"vol. 18","author":"Hong","year":"2018"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0020","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/17425247.2016.1158707","article-title":"Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy","volume":"13","author":"Yoon","year":"2016","journal-title":"Expert Opin. Drug Deliv"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0025","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.addr.2011.12.011","article-title":"Evolution of oncolytic adenovirus for cancer treatment","volume":"64","author":"Choi","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0030","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.biomaterials.2010.10.031","article-title":"Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin","volume":"32","author":"Kim","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0035","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2217\/nnm-2016-0060","article-title":"Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy","volume":"11","author":"Kasala","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biomaterials.2017.09.009","article-title":"A hydrogel matrix prolongs persistence and promotes specific localization of an oncolytic adenovirus in a tumor by restricting nonspecific shedding and an antiviral immune response","volume":"147","author":"Jung","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.biomaterials.2017.08.035","article-title":"Synergistic antitumor effect mediated by a paclitaxel-conjugated polymeric micelle-coated oncolytic adenovirus","volume":"145","author":"Kasala","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jconrel.2011.06.014","article-title":"Viral genome DNA\/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery","volume":"155","author":"Kwon","year":"2011","journal-title":"J. Control. Release Off. J. Control. Release Soc"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0055","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/mt.2009.194","article-title":"Cell carriers for oncolytic viruses: Fed Ex for cancer therapy","volume":"17","author":"Willmon","year":"2009","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0060","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jcyt.2016.09.003","article-title":"Genetically modified mesenchymal stromal cells in cancer therapy","volume":"18","author":"Sage","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0065","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/j.1582-4934.2011.01509.x","article-title":"Immunogenicity of allogeneic mesenchymal stem cells","volume":"16","author":"Schu","year":"2012","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0070","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1089\/hum.2010.135","article-title":"Mesenchymal stem cells and cancer: tumor-specific delivery vehicles or therapeutic targets?","volume":"21","author":"Dwyer","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2010.05.015","article-title":"Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy","volume":"147","author":"Hu","year":"2010","journal-title":"J. Control. Release Off. J. Control. Release Soc"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0080","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-04-1874","article-title":"Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas","volume":"65","author":"Nakamizo","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0085","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/stem.665","article-title":"Mesenchymal stem cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer","volume":"29","author":"Dwyer","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0090","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/hep.22236","article-title":"Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo","volume":"47","author":"van Poll","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0095","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/cbr.2011.1024","article-title":"Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma","volume":"26","author":"Serakinci","year":"2011","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0100","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1158\/1078-0432.CCR-09-1292","article-title":"Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model","volume":"15","author":"Mader","year":"2009","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/cgt.2009.67","article-title":"Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells","volume":"17","author":"Dembinski","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0110","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1634\/stemcells.2007-0758","article-title":"Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma","volume":"26","author":"Sonabend","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1634\/stemcells.21-4-389","article-title":"Approaches to utilize mesenchymal progenitor cells as cellular vehicles","volume":"21","author":"Pereboeva","year":"2003","journal-title":"Stem Cells"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0301-472X(00)00134-X","article-title":"Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells","volume":"28","author":"Conget","year":"2000","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0125","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ijc.29442","article-title":"Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells","volume":"137","author":"Hammer","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0130","doi-asserted-by":"crossref","first-page":"9706","DOI":"10.1128\/JVI.72.12.9706-9713.1998","article-title":"An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism","volume":"72","author":"Dmitriev","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0135","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/JVI.70.10.6839-6846.1996","article-title":"Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism","volume":"70","author":"Krasnykh","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0140","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/cgt.2010.4","article-title":"Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study","volume":"17","author":"Garcia-Castro","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0145","doi-asserted-by":"crossref","first-page":"45415","DOI":"10.18632\/oncotarget.17557","article-title":"Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model","volume":"8","author":"Rincon","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0150","article-title":"The targeted transduction of MMP-overexpressing tumor cells by ACPP-HPMA copolymer-coated adenovirus conjugates","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0155","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/jnci\/djt305","article-title":"Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound","volume":"105","author":"Carlisle","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.58","article-title":"EGFR-targeted adenovirus Dendrimer coating for improved systemic delivery of the Theranostic NIS gene","volume":"2","author":"Grunwald","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0165","article-title":"Combined genetic and chemical capsid modifications of adenovirus-based gene transfer vectors for shielding and targeting","volume":"140","author":"Jonsson","year":"2018","journal-title":"J. Vis. Exp"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijpharm.2018.04.051","article-title":"Design of PEI-conjugated bio-reducible polymer for efficient gene delivery","volume":"545","author":"Nam","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0175","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/jnci\/djj397","article-title":"Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy","volume":"98","author":"Kim","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2133.2011.10439.x","article-title":"Adenovirus-relaxin gene therapy for keloids: implication for reversing pathological fibrosis","volume":"165","author":"Lee","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jconrel.2015.09.018","article-title":"VEGF therapeutic gene delivery using dendrimer type bio-reducible polymer into human mesenchymal stem cells (hMSCs)","volume":"220","author":"Kim","year":"2015","journal-title":"J. Control. Release Off. J. Control. Release Soc"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0190","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1021\/bc700397x","article-title":"Novel biodegradable poly(disulfide amine)s for gene delivery with high efficiency and low cytotoxicity","volume":"19","author":"Ou","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0195","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1158\/1078-0432.CCR-08-2008","article-title":"Oncolytic adenoviral mutants with E1B19K gene deletions enhance gemcitabine-induced apoptosis in pancreatic carcinoma cells and anti-tumor efficacy in vivo","volume":"15","author":"Leitner","year":"2009","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jconrel.2013.03.030","article-title":"Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy","volume":"169","author":"Kwon","year":"2013","journal-title":"J. Control. Release Off. J. Control. Release Soc"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-006-9449-8","article-title":"Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma","volume":"105","author":"Stoff-Khalili","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0210","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1634\/stemcells.2006-0461","article-title":"Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells","volume":"25","author":"Xin","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0215","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1158\/0008-5472.CAN-08-4698","article-title":"Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer","volume":"69","author":"Loebinger","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0220","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jcyt.2016.12.003","article-title":"Biodistribution and retention of locally administered human mesenchymal stromal cells: quantitative polymerase chain reaction-based detection of human DNA in murine organs","volume":"19","author":"Creane","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0225","first-page":"3603","article-title":"Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors","volume":"62","author":"Studeny","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0230","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1535-7163.MCT-05-0334","article-title":"Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses","volume":"5","author":"Komarova","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0235","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/hum.2007.034","article-title":"Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors","volume":"18","author":"Hakkarainen","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0240","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1073\/pnas.98.3.1200","article-title":"Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini","volume":"98","author":"Putnam","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0245","first-page":"4637","article-title":"Cationic lipid-coated PEI\/DNA polyplexes with improved efficiency and reduced cytotoxicity for gene delivery into mesenchymal stem cells","volume":"7","author":"Song","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0250","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/bm501116x","article-title":"Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model","volume":"16","author":"Jung","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0255","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1021\/acs.bioconjchem.5b00357","article-title":"Tuning surface charge and PEGylation of biocompatible polymers for efficient delivery of nucleic acid or adenoviral vector","volume":"26","author":"Choi","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1476-4598-10-134","article-title":"Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors","volume":"10","author":"Xia","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0265","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13287-015-0271-2","article-title":"Biodistribution, migration and homing of systemically applied mesenchymal stem\/stromal cells","volume":"7","author":"Leibacher","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0270","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1128\/JVI.78.10.5368-5381.2004","article-title":"Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors","volume":"78","author":"Shayakhmetov","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0275","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cas.13228","article-title":"Recent advances in genetic modification of adenovirus vectors for cancer treatment","volume":"108","author":"Yamamoto","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0280","doi-asserted-by":"crossref","first-page":"E335","DOI":"10.21037\/jtd.2017.03.44","article-title":"Safety profile of EGFR-targeted hybrid vector system composed of PAMAM dendrimer and oncolytic adenovirus","volume":"9","author":"Yoon","year":"2017","journal-title":"J. Thorac. Dis"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0285","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jconrel.2015.01.005","article-title":"pH-sensitive oncolytic adenovirus hybrid targeting acidic tumor microenvironment and angiogenesis","volume":"205","author":"Choi","year":"2015","journal-title":"J. Control. Release Off. J. Control. Release Soc"},{"key":"10.1016\/j.jconrel.2019.04.040_bb0290","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.3267","article-title":"Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies","volume":"19","author":"Lee","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2019.04.040_bb0295","unstructured":"U.S. FDA, (in) https:\/\/www.fda.gov\/consumers\/consumer-updates\/fda-warns-about-stem-cell-therapies."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919302433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919302433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T03:09:09Z","timestamp":1607656149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919302433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":59,"alternative-id":["S0168365919302433"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.04.040","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}